NSE: SHARDACROP | BSE: 538666

Strong Performer, Under Radar

Download real time

1033.20 -3.50 (-0.34%)

128.46% Gain from 52W Low

223.6K NSE+BSE Volume

NSE 12 Mar, 2026 3:31 PM (IST)

9,321.6

Market Cap

High in industry

Beta 1Year

Very High Volatility

Sharda Cropchem Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SHARDACROP, BSE:538666 Sharda Cropchem Ltd.

Search Inside the pdf :

Sharda Cropchem Ltd.

02 Feb 2026

1033.20

-0.34%

SHARDA CROPCHEM LIMITED

Buy: Sharda Cropchem Ltd.

Geojit BNP Paribas

The RSI has surged into the bullish zone near 65, indicating strong momentum; while this suggests elevated activity, it also reflects renewed buying strength following the breakout. The MACD has turned positive, with a bullish crossover and a rising histogram, confirming...

Sharda Cropchem has gained 83.71% in the last 1 Year

Sharda Cropchem Ltd.

02 Feb 2026

1033.20

-0.34%

Registration pipeline and market recovery support outlook

Buy: Sharda Cropchem Ltd.

Target

Khambatta Securities

Sharda Cropchem Limited (SCL) reported a solid revenue growth of 38.7% y-o-y in 3Q FY26, reaching Rs 1,288.8 crore. This growth was primarily driven by volume growth of 14.4% and change in the product mix.

Sharda Cropchem Ltd. is trading below its 30 day SMA of 1138.3

Sharda Cropchem Ltd.

30 Jan 2026

1033.20

-0.34%

Continued outperformance momentum to sustain; maintain BUY

Buy: Sharda Cropchem Ltd.

Target

Anand Rathi

Sharda Cropchem continued to outperform in Q3FY26, aided by healthy, 14% y/y volume growth, positive product-mix and favourable forex and market-share gain in its key regions.

Sharda Cropchem Ltd. is trading below its 30 day SMA of 1138.3

Sharda Cropchem Ltd.

05 Dec 2025

1033.20

-0.34%

Factory-to-Farmer

buy: Sharda Cropchem Ltd.

FundsIndia

Edge: High-entry-barrier regulatory portfolio + scalable global network

Number of FII/FPI investors decreased from 114 to 106 in Dec 2025 qtr

Sharda Cropchem Ltd.

04 Nov 2025

1033.20

-0.34%

Inventory normalization across distribution channels support outlook

Buy: Sharda Cropchem Ltd.

Target

Khambatta Securities

SCL reported a robust performance in 2Q FY26, driven by strong volume growth and margin expansion. The Company remains optimistic about a gradual recovery in the global agrochemical market, noting that inventories have normalized across distribution channels.

Number of FII/FPI investors decreased from 114 to 106 in Dec 2025 qtr

Sharda Cropchem Ltd.

01 Nov 2025

1033.20

-0.34%

Yet another solid quarter; momentum to persist; retaining a Buy

Buy: Sharda Cropchem Ltd.

Anand Rathi

Healthy, 35% y/y, volume growth and market-share gains in its key regions drove Sharda Cropchem’s Q2 results. Growth improved on better demand particularly in NAFTA and Europe coupled with near complete de-stocking across major regions.

Sharda Cropchem Ltd. is trading above its 200 day SMA of 906.7

Sharda Cropchem Ltd.

21 Aug 2025

1033.20

-0.34%

Global agrochemical recovery fuels positive outlook

Buy: Sharda Cropchem Ltd.

Recommendation Target

Khambatta Securities

Sharda Cropchem Limited (SCL) reported a 25% y-o-y increase in total revenue for 1Q FY26, reaching Rs 984.8 crore.

Sharda Cropchem Ltd. is trading below its 30 day SMA of 1138.3

Sharda Cropchem Ltd.

28 Jul 2025

1033.20

-0.34%

Solid start to FY26; momentum to continue; retaining a Buy

Buy: Sharda Cropchem Ltd.

Target

Anand Rathi

Healthy, 13% y/y, volume growth and market-share gains in its key regions drove Sharda Cropchem’s Q1 results. Growth improved on the back of better demand scenario particularly in Europe and a near complete destocking across major regions.

Number of FII/FPI investors decreased from 114 to 106 in Dec 2025 qtr

Sharda Cropchem Ltd.

03 Jun 2025

1033.20

-0.34%

Price recovery to fuel revenue growth

Hold: Sharda Cropchem Ltd.

Recommendation Target

Khambatta Securities

Sharda Cropchem Limited (SCL) reported solid growth in 4Q FY25 as revenues increased by 39.4% y-o-y to Rs 1,828.5 crore. This robust quarterly growth was mirrored by a strong overall top-line performance for the entirety of FY25.

Sharda Cropchem Ltd. is trading above its 200 day SMA of 906.7

Is Sharda Cropchem Ltd. worth buying?

178 Votes:

Buy 80.34%

Sell 11.8%

Hold 7.87%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf